What is NOEM's deferred tax assets, valuation allowance?

NOEM (NOEM) reported deferred tax assets, valuation allowance of $248.51K in Q4 2025.

What is the long-term trend for NOEM's deferred tax assets, valuation allowance?

Over 2 years (2023 to 2025), NOEM's deferred tax assets, valuation allowance has grown at a 66.0% compound annual growth rate (CAGR), from $90.21K to $248.51K.

NOEM NOEM Deferred Tax Assets, Valuation Allowance

Deferred Tax Assets, Valuation Allowance at other companies

Cineverse Corp.CNVS

$31.36M+0.7%

Envoy MedicalCOCH

$654K+2.5%

State StreetSTT

$198M+15.1%

OFG BancorpOFG

$568K-87.9%

BKBK

$127M-5.9%

PepsiCoPEP

$6.12B-1.1%

Other financials

Income statement

See full

Operating income-$196.7K-15.2%

Net income$309.2K-23.9%

EPS (diluted)-$0.01—

Balance sheet

See full

Cash & equivalents$26.1K-95.9%

Total debt$11.7K—

Total equity-$2.0M-33.3%

Total assets$72.1M+1.7%

Cash flow

See full

Operating cash flow-$1.1M-237%

Valuation

See full

Market cap$100.08M+3.5%

P/E64.4×-47.0×

Returns & leverage

See full

Return on equity-90.8%—

Current ratio2.6×+0.7×

Where this comes from

Reported directly by NOEM in its filing.

Tagged under the XBRL concept us-gaap:DeferredTaxAssetsValuationAllowance.

The official record: NOEM’s 10-K, filed March 16, 2026, on SEC EDGAR. View the filing →

Ask your AI about NOEM's deferred tax assets, valuation allowance.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is NOEM's deferred tax assets, valuation allowance?: NOEM (NOEM) reported deferred tax assets, valuation allowance of $248.51K in Q4 2025.
What is the long-term trend for NOEM's deferred tax assets, valuation allowance?: Over 2 years (2023 to 2025), NOEM's deferred tax assets, valuation allowance has grown at a 66.0% compound annual growth rate (CAGR), from $90.21K to $248.51K.